Home

Insights

Sun Pharmaceuticals Industries Ltd dividend

Sun Pharmaceuticals Industries Ltd dividend

download
stocks purchased

₹ 0.8 Cr

Volume transacted

stocks purchased

5.5 K

stocks traded

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

DPS

11.5

Last updated : FY 2023

Key Highlights

    The Dividend per Share of Sun Pharmaceuticals Industries Ltd is ₹ 11.5 as of 2023 .a1#The Dividend Payout of Sun Pharmaceuticals Industries Ltd changed from 80.8 % on March 2019 to 163.2 % on March 2023 . This represents a CAGR of 15.10% over 5 years. a1#The Latest Trading Price of Sun Pharmaceuticals Industries Ltd is ₹ 1530 as of 18 May 15:30 .a1#The Market Cap of Sun Pharmaceuticals Industries Ltd changed from ₹ 114988 crore on March 2019 to ₹ 235878 crore on March 2023 . This represents a CAGR of 15.45% over 5 years. a1#The Revenue of Sun Pharmaceuticals Industries Ltd changed from ₹ 10763 crore to ₹ 12630 crore over 7 quarters. This represents a CAGR of 9.57% a1#The EBITDA of Sun Pharmaceuticals Industries Ltd changed from ₹ 2886 crore to ₹ 3657 crore over 7 quarters. This represents a CAGR of 14.48% a1#The Net Profit of Sun Pharmaceuticals Industries Ltd changed from ₹ 2095 crore to ₹ 2568 crore over 7 quarters. This represents a CAGR of 12.31% a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

Share Price Vs Dividend Yield

swot
swot

Fundamental Metrics

Market Cap

368,597 Cr

EPS

39.1

P/E Ratio (TTM) *

39.3

P/B Ratio (TTM) *

6.2

DTE *

0.0

ROE *

14.3

ROCE *

16.5

Dividend Yield *

1.17

DPS *

11.5

Dividend Payout *

163.2

Ann.Dividend % *

1150

* All values are consolidated

* All values are consolidated

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '1981
Mar '2030
Mar '21214
Mar '22-2400
Mar '23163

* All values are a in %

Dividend per Share (DPS) Over Time

×

DIVIDENDYIELD

Dividend Yield is a financial ratio that shows the annual dividend income relative to the market price of a share. It is calculated by dividing the dividend per share by the current market price per share, expressed as a percentage.

Dividend Yield Comparison With Top Peers

1M

1Y

3Y

5Y

* All values are in %

Net Profit Vs Dividend Per Share

Image

Sun Pharmaceuticals Industries Ltd

NSE: SUNPHARMA

PRICE

1530.8

-0.75(-0.05%)

stock direction

Last updated : 18 May 15:30

SWOT Analysis Of Sun Pharmaceuticals Industries Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Sun Pharmaceuticals Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Dividend Overview for Sun Pharmaceuticals Industries Ltd

  • Sun Pharmaceuticals Industries Ltd, boasts of a market capitalization of Rs 368598 Cr., with a share price of Rs 1530.80 as of 18 May 15:30. While all stocks don't consistently pay dividends, Sun Pharmaceuticals Industries Ltd rewarded its shareholders, distributing 163.2 % for the full year.
  • In the year ending 2022, Sun Pharmaceuticals Industries Ltd declared a dividend of Rs 10, resulting in a dividend yield of 1.1% Assessing its dividend-paying capacity and valuation is crucial to determine its suitability as a dividend stock.
  • During the year ending 2023, Sun Pharmaceuticals Industries Ltd recorded revenues of Rs 46671 Cr, with a trailing EBITDA Margin of 28.6% and net-profit of Rs 8906 Cr

Overview of Dividend

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '19114988
Mar '2084505
Mar '21143384
Mar '22219491
Mar '23235879

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '2210764
Sep '2211038
Dec '2211415
Mar '2211304
Jun '2312145
Sep '2312486
Dec '2312631

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '222887
Sep '223042
Dec '223178
Mar '223004
Jun '233213
Sep '233473
Dec '233657

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '222096
Sep '222260
Dec '222188
Mar '222017
Jun '232013
Sep '232401
Dec '232568

* All values are a in crore

About Sun Pharmaceuticals Industries Ltd

About Sun Pharmaceuticals Industries Ltd

    Sun Pharmaceutical Industries Limited including its subsidiaries and associates (Sun Pharma) is the fourth largest global specialty generic company that is ranked No. In the year 1998, the company established their first research center, SPARC and this created the base for strong product and process development that enabled growth in the subsequent years. Also, the company acquired equity stake in Gujarat Lyka Organics Ltd., a manufacturer of Cephalexin Active with a USFDA approval for the intermediate, 7ADCA. In the year 1998, the company acquired a basket of products, including several respiratory/asthma brands acquired from Natco Pharma. During the year, the company completed the construction at a formulation manufacturing site at Jammu. In June 14, 2011, Caraco Pharmaceutical Laboratories Ltd (Caroco) merged with a subsidiary of the company. The Company announces USFDA approval for generic Prevacid, generic DoxilAr and generic DepoAr-Testosterone Injection. The acquired brands will be marketed by a reliable and established local marketing partner under the Sun Pharma label. The purpose of the buyback is to return surplus funds to the equity shareholders and thereby, enhancing the overall returns to shareholders. On 18 July 2016, Sun Pharma and Sun Pharma Advanced Research Company Ltd. (SPARC) announced a licensing arrangement for SPARC's ELEPSIA XR (Levetiracetam Extended Release tablets). Sun Pharma will be eligible to receive development and regulatory milestone payments and, additionally, sales milestone payments and royalties on net sales. It was the first branded product launched by the company in the USA following its focus on Specialty Business. On 22 December 2016, Sun Pharma announced its plans to acquire a branded oncology product Odomzo from Novartis. The agreement was signed for an upfront payment of US$ 175 million and additional milestone payments. The USFDA had taken action against the Mohali facility in 2013 when it ordered the facility to be fully subject to Ranbaxy's Consent Decree of Permanent Injunction. Sun Pharma will provide drug molecules to NIV for testing against Zika, Chikungunya and Dengue in model systems. These RTA bags will provide greater safety, by preventing problems of over-dosing or under-dosing and eliminating contamination risk. In August 2019, Sun Pharma granted an exclusive license to a subsidiary of China Medical System Holdings Ltd. (CMS) to develop and commercialise seven generic products in Mainland China. In November 2019, Sun Pharma entered into a licensing agreement with AstraZeneca UK Ltd. (AstraZeneca) to introduce certain novel ready to use (RTU) infusion oncology products in China. It initiated Phase-2 clinical trials for a potential oral treatment for atopic dermatitis and moderate to severe plaque psoriasis.

Sun Pharmaceuticals Industries Ltd News Hub

News

Sun Pharmaceuticals Industries to hold board meeting

Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Compan...

Read more

13 May 2024 17:24

News

Sun Pharmaceuticals Industries Ltd slips for fifth straight session

Sun Pharmaceuticals Industries Ltd dropped for a fifth straight session today. The stock i...

Read more

08 Apr 2024 13:35

News

Sun Pharmaceuticals Industries Ltd spurts 2.46%, rises for third straight session

Sun Pharmaceuticals Industries Ltd rose for a third straight session today. The stock is q...

Read more

22 Mar 2024 13:05

News

Sun Pharma receives nod to launch Winlevi� in Australia

Sun Pharmaceutical Industries announced that the Australian Therapeutic Goods Administrati...

Read more

19 Mar 2024 09:32

News

Sun Pharmaceuticals Industries Ltd soars 0.82%, up for fifth straight session

Sun Pharmaceuticals Industries Ltd gained for a fifth straight session today. The stock is...

Read more

11 Mar 2024 13:00

News

Sun Pharmaceuticals Industries Ltd spurts 0.04%, gains for five straight sessions

Sun Pharmaceuticals Industries Ltd rose for a fifth straight session today. The stock is q...

Read more

22 Feb 2024 13:00

FAQs for dividends of Sun Pharmaceuticals Industries Ltd

What is the current market price of Sun Pharmaceuticals Industries Ltd Ltd as of May 20, 2024?

The current market price of Sun Pharmaceuticals Industries Ltd Ltd stands at 1530.8 per share.

What dividend did Sun Pharmaceuticals Industries Ltd declare in the last fiscal year?

In the last fiscal year, Sun Pharmaceuticals Industries Ltd declared a dividend totaling ₹11.5.

What is the most recent dividend declared by Sun Pharmaceuticals Industries Ltd?

Sun Pharmaceuticals Industries Ltd recently declared a dividend of 8.5 in the latest quarter

How many times has Sun Pharmaceuticals Industries Ltd declared dividends in the current fiscal year

Sun Pharmaceuticals Industries Ltd has declared dividends 3 times totaling ₹9 in the current fiscal year (FY2023-2024).

How many times did Sun Pharmaceuticals Industries Ltd declare dividends in the previous fiscal year?

In the previous fiscal year (FY2022-2023), Sun Pharmaceuticals Industries Ltd declared dividends 4 times totaling ₹8.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199